Project Updates
Spark Therapeutics
Credit; Commonwealth of Pennsylvania.
Location: Philadelphia, USA
Project type: Gene Therapy Innovation Center
Expected Completion: 2026
Estimated Investment: Phase 1: $575m
Spark Therapeutics, a US-based biotechnology company and a member of the Roche Group, began construction of a new Gene Therapy Innovation Center on Drexel University’s campus. The facility will serve as Roche’s global centre of excellence for gene therapy manufacturing.
Boehringer Ingelheim
Credit; Boehringer Ingelheim
Location: Biberach, Germany
Project type: Research and development facility
Construction Started: June 2018
Completed: April 2023
Boehringer Ingelheim developed a biologicals development centre and invested €350m ($384.6m) in the state-of-the-art facility. It is Europe’s largest development centre in biotechnology. The facility is used for conducting advanced research for cancer, stroke and heart disease and other conditions.
Cellares
Credit; Cellares Corporation
Location: Bridgewater, New Jersey, US
Project type: Cell therapy development facility
Estimated Investment: $255m
Expected Completion: 2024
Cellares, a US-based Integrated Development and Manufacturing Organization (IDMO) focused on cell therapy, will launch its first IDMO Smart Factory in Bridgewater, New Jersey, US, for pre-clinical, clinical and commercial-scale cell therapy manufacturing.
